Target intelligence / Profile preview

Ocular surface proteins

Molecular classification
Other (heterogeneous group; includes mucins, glycoproteins, tight junction proteins, antimicrobial peptides, and more[1][2][3])
01

Overview

Ocular surface proteins are a broad collection of molecules present on or within the tissues of the ocular surface, including the corneal and conjunctival epithelia, tear film, and associated glandular secretions[1][2][3]. Key protein classes include membrane-bound and secreted mucins (e.g., MUC1, MUC4, MUC5AC, MUC16), adhesion molecules like cadherins in tight junctions, antimicrobial peptides (e.g., defensins, lysozyme, lactoferrin), and various glycocalyx components[1][2][3]. These proteins collectively maintain the physical barrier protecting the eye from pathogens and environmental insults, mediate immune responses, preserve hydration and optical properties, and enable rapid healing after injury. Disruption of these protein systems is implicated in conditions such as dry eye disease, infections, and other ocular surface disorders[1][2][3]. Because "ocular surface proteins" refers to a large, heterogeneous group rather than a single, druggable therapeutic target, the entry should be flagged as nonspecific and not suitable for a canonical target list. If analysis of specific ocular surface targets (e.g., "Mucin 16" or "Galectin-3") is desired, those should be addressed individually.

Other names
Ocular surface barrier proteinsOcular surface mucinsOcular glycocalyx proteinsCorneal epithelial proteins
02

Mechanism of action

Not applicable (this is not a single drug target; drugs can aim to restore barrier function or modulate inflammation[1])

03

Biological functions

Barrier functionInnate immune defenseMaintenance of hydration (tear film stability)Cell adhesion and signaling[1][2][3]
04

Disease associations

InflammationInfectionDry eye diseaseOcular surface disorders (broadly)[1][2]
05

Safety considerations

Drug delivery challenges due to barrier function
06

Interacting drugs

None specific (topical drugs such as lubricants, immune modulators, and antimicrobials generally interact with the ocular surface)
07

Biomarkers

Tear fluid protein composition (e.g., mucin MUC5AC, lactoferrin, lysozyme) as biomarkers for ocular surface health or disease[1]

Beyond the preview

Go deeper on Ocular surface proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call